Urso L, Panareo S, Castello A, Ambrosio MR, Zatelli MC, Caracciolo M, Tonini E, Valpiani G, Boschi A, Uccelli L, Cittanti C, Bartolomei M. Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial. Pharmaceutics 2022;14:2009. [DOI: 10.3390/pharmaceutics14102009][Cited by in F6Publishing: 1][Reference Citation Analysis]
3
Nosov NA, Popov SA, Rozengauz EV, Stanzhevskii AA, Mus VF, Maystrenko DN. <sup>68</sup>Ga-DOTATATE PET/CT Capabilities in Diagnosing of Neuroendocrine Tumors Recurrence. jour 2022;5:18-28. [DOI: 10.37174/2587-7593-2022-5-3-18-28][Reference Citation Analysis]